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Summary
Objective: Growth plate chondrocytes up-regulate calcium-sensing receptor (CaR) expression as they mature to hypertrophy. In cells other
than chondrocytes, extracellular calcium-sensing via the CaR functions partly to promote expression of parathyroid hormone-related protein
(PTHrP), a critical regulator of endochondral development. Moreover, PTHrP is up-regulated in human osteoarthritis (OA) and surgically
induced rabbit OA cartilages and may promote both chondrocyte proliferation and osteophyte formation therein. Hence, we examined
chondrocyte CaR-mediated calcium-sensing in OA pathogenesis.
Methods: We studied spontaneous knee OA in male Hartley guinea pigs. We also evaluated cultured bovine knee chondrocytes and
immortalized human articular chondrocytes (CH-8 cells), employing the CaR calcimimetic agonist NPS R-467 or altering physiologic
extracellular calcium (1.8 mM).
Results: Immunohistochemistry revealed that CaR expression became up-regulated in the superﬁcial zone at 4 months of age in the guinea
pig medial tibial plateau cartilage as early OA developed. CaR expression later became up-regulated in the middle zone. PTHrP content,
measured by immunoassay, was signiﬁcantly increased in the medial tibial plateau cartilage as OA developed and progressed. In cultured
chondrocytic cells, CaR-mediated extracellular calcium-sensing, stimulated by the calcimimetic NPS R-467, induced PTHrP and matrix
metalloproteinase (MMP)-13 expression and suppressed expression of tissue inhibitor of metalloproteinase (TIMP)-3 dose-dependently,
effects shared by elevated extracellular calcium (3 mM). Extracellular calcium-sensing appeared essential for PTHrP and interleukin (IL)-1 to
induce MMP-13 and for PTHrP 1-34 to suppress TIMP-3 expression.
Conclusions: Chondrocyte CaR expression becomes up-regulated early in the course of spontaneous guinea pig knee OA. Chondrocyte CaR-
mediated extracellular calcium-sensing promotes PTHrP expression, modulates the effects of PTHrP and IL-1, and promotes MMP-13
expression and TIMP-3 depletion. Our results implicate up-regulated extracellular calcium-sensing via the CaR as a novel mediator of OA
progression.
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The development of foci of chondrocyte proliferation and
hypertrophy and of pathologic calciﬁcation in osteoarthritis
(OA) cartilage suggests that altered differentiation of
articular chondrocytes in OA at least partially recapitulates
events critical to the physiologic remodeling of cartilage in
the growth plate involved in mineralization1,2. One of the
essential mediators of normal endochondral cartilage
development and growth plate mineralization is locally
produced parathyroid hormone-related protein (PTHrP)3e8.
By modulating both synthesis and degradation of the matrix,
as well as chondrocyte growth, differentiation, and survival,
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growth plate chondrocytes3e6. In this context, PTHrP
regulates type II collagen, aggrecan, and link protein
expression3,5,7,8, and PTHrP also can induce matrix metal-
loproteinase (MMP)-2, MMP-9, and MMP-139,10. PTHrP
also promotes endochondral chondrocyte proliferation3,5
and suppresses development of apoptosis4. PTHrP also
suppresses maturation of chondrocytes to hypertrophic
differentiation3,6 via effects including modulation of expres-
sion of the runx2/cbfa1 transcription factor11, regulation of
phosphorylation and the transcriptional activity of the
chondrogenic transcription factor Sox912, and co-ordination
with Indian Hedgehog signaling13.
We have demonstrated articular chondrocyte expression
of the PTH/PTHrP receptor (also termed PTH1R) and
robustly up-regulated expression of PTHrP in situ in human
knee cartilages with advanced OA14. In late-stage rabbit
knee OA surgically induced by partial medial meniscec-
tomy, increased PTHrP expression developed in proliferat-
ing chondrocytes, a ﬁnding whose signiﬁcance was
underscored by the decrease in articular chondrocyte5
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the rabbit15. Recently, we observed that the human-speciﬁc
PTHrP 1-173 isoform exerted potent intracrine effects on
collagen synthesis and extracellular concentrations of the
mineralization regulator inorganic pyrophosphate16.
One of the major inducers of PTHrP expression identiﬁed
in vitro in cells other than chondrocytes is the sensing of
extracellular calcium by the G protein-linked calcium-
sensing receptor (CaR)17,18. Extracellular calcium is un-
equivocally the primary agonist of the CaR, and, in turn, the
CaR is the primary cell sensor for extracellular calcium19,20.
In the parathyroid gland, the CaR mediates exquisitely
sensitive responsiveness to extracellular calcium that exerts
critical control over PTH secretion16,18. In the kidney, CaR
expression functions as a sensing mechanism to modulate
tubular ion transport21. But cells outside the parathyroid
gland and kidney are generally less responsive to extracel-
lular calcium than PTH-secreting cells in the parathyroid,
consistent with marked effects of the environment in which
the CaR sees extracellular calcium on cellular responses to
calcium19,20. Previous studies of CaR expression and
calcium-sensing in chondrogenic cell lines demonstrated
suppressive effects of calcium-sensing on proteoglycans
synthesis and aggrecan and type II collagen expres-
sion22e24. The capacity of calcium-sensing to promote
chondrogenesis as well as chondrocyte maturation to
hypertrophy associated with osteopontin expression and
mineralization also has been demonstrated25. Signiﬁcantly,
CaR expression becomes up-regulated in association with
chondrocyte hypertrophy in the growth plate23.
Given the aforementioned observations and the fact that
most normal articular chondrocytes express low levels of
CaR transcripts in situ23, this study examined the knee
articular cartilages of Hartley guinea pigs, which spontane-
ously develop OA26e28, for expression of CaR, PTHrP, and
the PTH/PTHrP receptor at early and progressively more
advanced time points. To better understand the potential
roles playedby chondrocytePTHrPandcalcium-sensingand
CaR expression in OA, we investigated cultured normal
bovine chondrocytes and immortalized normal human knee
chondrocytic CH-8 cells29. We focused on the potential
effects of calcium-sensing on not only PTHrP release
by chondrocytic cells but also on speciﬁc chondrocyte
responses that modulate OA progression [i.e., interleukin
(IL)-1 responsiveness, and expression of the MMP and
aggrecanase inhibitor TIMP-3 (tissue inhibitor of metal-
loproteinase-3)]30e32. Our results reveal a potential direct
role in the pathogenesis of OA of up-regulated extracellular
calcium-sensing via enhancedchondrocyteCaRexpression.
Materials and methods
REAGENTS
All chemical reagents were obtained from Sigma Chem-
icals (St. Louis, MO) unless otherwise speciﬁed. Synthetic
PTHrP 1-34 was purchased from Bachem (Torrance, CA),
and IL-1b was from R&D Systems (Minneapolis, MN). The
calcimimetic CaR agonist NPS R-46733 was generously
provided by NPS Pharmaceuticals (Salt Lake City, UT).
Tissue culture medium and antibiotic solutions were
purchased from Mediatech (Herdon, VA).
ANIMALS
Male Hartley guinea pigs were obtained from Charles
River Laboratories (Wilmington, MA) and fed with standardguinea pig chow from the same source that contained
0.85 g calcium/100 g. All animal experiments were per-
formed in accordance with the National Institutes of Health
(NIH) Guidelines for the Care and Use of Laboratory
Animals.
CARTILAGE TISSUE COLLECTION, CHONDROCYTE
ISOLATION, AND CULTURE
After dissection of each hind knee in euthanized guinea
pigs, uncalciﬁed articular cartilage was removed from the
tibial plateau, and samples were taken as previously
described28. In brief, full thickness slices (!1 mm) were
cut from the medial central hyaline cartilage zone not
covered by menisci (width! length; 2! 3 mm) and the
meniscal ﬁbrocartilage zone (3! 3 mm) of 2-, 4-, and
8-month-old animals. Washed cartilage samples were
cultured in Dulbecco’s modiﬁed Eagle’s (DME’s) medium
(high glucose), supplemented with 2 mM L-glutamine, 100
Units/ml penicillin, and 50 mg/ml streptomycin (‘‘standard
growth medium’’), and heat-inactivated 1% fetal bovine
serum (FBS). Where indicated, guinea pig knee chondro-
cytes were isolated and cultured in the same medium, as
described in detail28, speciﬁcally for assays of PTHrP
release. The cartilage slices were extracted in 50 mM Tris,
pH 7.5, 0.25 M NaCl, 0.1% NP 40, 1% Triton X-100, 5 mM
ethylenediaaminetetraacetic acid (EDTA), and 5 mM NaF,
and were stored at 70(C until further processing.
Bovine chondrocytes were isolated by collagenase
digestion of mature normal knees (Animal Technologies,
Tyler, TX), and cells were plated in standard growth
medium for 7 days before evaluating the cells in functional
studies in monolayer, as described34.
Clonal human chondrocytic cells (CH-8) from adenoviral
SV40 early gene-immortalized normal knee articular chon-
drocytes29 exhibited continuous proliferative capacity in
monolayer culture and maintained chondrocytic differentia-
tion, veriﬁed by expression of collagen type II and aggrecan
detected by reverse transcription-polymerase chain re-
action (RT-PCR). Here, CH-8 cells (passages 4e10) were
studied in monolayer culture in dishes coated with type II
collagen in standard growth medium, supplemented with
10% FBS.
IMMUNOHISTOCHEMISTRY
Guinea pig knees were dissected, ﬁxed in 10% formal-
dehyde/HCl to decalcify the bone and parafﬁn-embedded
6 mm sections from the central portion of the medial tibial
plateau articular cartilage were microtomed and placed onto
(C) charged microscope slides (Fisher Scientiﬁc, Pitts-
burgh, PA), as previously described28. Sections were
deparafﬁnized in xylene and hydrated through a graded
ethanol series. Safranin O staining was performed on the
sections to identify the cartilage. Sections were heated at
95(C in 10 mM sodium citrate buffer, pH 6.0, for antigen
retrieval and quenching of endogenous horseradish perox-
idase activity. Nonspeciﬁc protein binding was blocked with
20% FBS, 0.25% gelatin in phosphate buffered saline
(PBS) for 30 min. Sections were incubated with primary
antibodies for PTHrP (the murine PTHrP antibody 9H7)14,
the PTH/PTHrP receptor (generously provided by Dr. Mitch
Scott, Washington Univ., St. Louis, MO), and CaR (Afﬁnity
Bioreagents, Golden, CO) diluted in 0.25% gelatin in PBS
overnight at 4(C. Biotinylated goat anti-mouse or rabbit
antibody (Calbiochem, San Diego, CA), diluted at 1:200
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were washed and then incubated with streptavidinehorser-
adish peroxidase conjugate. The staining was developed
with the chromogen 3,3#-diaminobenzidine tetrahydrochlor-
ide and hydrogen peroxide in 25 mM Tris, pH 7.4. Negative
controls included omitting the primary antibody and, for
PTHrP, preadsorbing the primary antibodies with 100 molar
excess of immunizing antigen. Positive controls for immuno-
staining included sections from parafﬁn-embedded human
lung cancer-derived BEN cells and sections from parafﬁn-
embedded osteogenic sarcoma-derived SaOS-2 cells.
PTHrP IMMUNOASSAY
Guinea pig cartilage explants and bovine chondrocyte
and CH-8 cell conditioned media were measured for PTHrP
by radioimmunoassay14,16. In brief, human PTHrP 1-34
peptide was used as standard and PTHrP 1-86 peptide was
radioiodinated by the chloramine T method. A rabbit PTHrP
antibody (R869) directed against PTHrP 1-34 was used for
the measurements of PTHrP levels in 3 days non-
equilibrium immunoassay format, as described14. All
samples were assayed in triplicate in multiple dilutions that
paralleled the corresponding PTHrP standard curve. The
intra- and inter-assay variations were approximately
7e12%, and the limit of assay sensitivity was 4 pmol per
liter. The unknown sample B/Bo values were on the linear
portion of the radioimmunoassay standard curve using
100 ml sample/tube. Lack of cross-reactivity in the assay for
at least a 100-fold excess of peptide was demonstrated for
non-corresponding PTHrP peptides, PTH 1-84, calcitonin,
calcitonin gene-related peptide, and human and rat atrial
natriuretic peptide.
STUDIES OF CALCIUM-SENSING IN CULTURED CELLS
Aliquots of 3.0! 105 CH-8 cells and bovine chondro-
cytes in 6-well culture plates pre-coated with type II collagen
were placed in DME formulated with no calcium salts (DME-
no Ca) (Invitrogen, Carlsbad, CA). IL-1b (10 ng/ml) and
PTHrP 1-34 (10 nM) were added to the DME-no Ca2C
medium supplemented with CaCl2 (0.5 mM, 1.8 mM, or
3.0 mM) and 1% FBS, 250 Units penicillin, 50 mg/ml
streptomycin, and 2 mM glutamine. For NPS R-467 studies,
cells were treated in DME-no Ca2C supplemented with 1%
FBS and 0.5 mM Ca2C, the media replaced at 3 days in
culture, and at 5 days, conditioned media were collected
and cell lysates were collected in 150 mM NaCl, 0.5 mM
EDTA, 1 mM ethylene glycol-bis(2-aminoethylether)-
N,N,N#,N#-tetraacetic acid, 1% sodium dodecyl sulfate
(SDS), 1 mM sodium orthovanadate, and supplemental
protease inhibitors in 10 mM Tris HCl, pH 7.6.
WESTERN BLOT ANALYSES
Aliquots containing 15 mg of protein/well were separated
by 10% SDS-PAGE (SDS-polyacrylamide gel electropho-
resis) and electroblotted onto nitrocellulose membranes
(Bio-Rad Laboratories, Hercules, CA), as described34.
Antibodies to MMP-13 (Oncogene, San Diego, CA) and
TIMP-3 (Santa Cruz Biotechnology, Santa Cruz, CA) were
used at 1:100 and 1:1000, respectively, in blocking buffer
and incubated for 18 h at 4(C. Secondary antibodies [goat
anti-rabbit or anti-mouse conjugated to horseradish perox-
idase (Santa Cruz Biotechnology, Santa Cruz, CA)] were at
1:1000. Optical densities of bands were quantiﬁed using theFluorChem 8900 image analysis system (Alpha Innotech,
San Leandro, CA).
RT-PCR
Expression of PTHrP, PTH/PTHrP receptor and CaR
messenger RNAs (mRNAs) were evaluated by RT-PCR
analyses on total RNA, as described14. All PCR products
were sequenced to conﬁrm the ﬁdelity of ampliﬁcation.
Primer sets used were: CaR: forward 5#-GCAACACAC
CCATTGTCAAG-3# and reverse 5#-GGCAAAGAAGAA
GCAGATGG-3#, PTH/PTHrP receptor: forward 5#-GTG
AACGGGAGGTGTTTGA-3# and reverse 5#-CCCGGACGA
TATTGATGAAG-3, and glyceraldehydes-3-phosphate de-
hydrogenase (GAPDH): forward 5#-GGAGTCAACGGATT
TGGT-3# and reverse 5#-GTGATGGGATTTCCATTG
AT-3#.
STATISTICS
Statistical analyses were performed using Microsoft
Excel (Microsoft Corp., Redmond, WA) and Statview
(SAS, Cary, NC) software, with results reported as mean -
G S.E.M. and differences among treatment groups assessed
using single factor analysis of variance.
Results
PTHrP, PTH/PTHrP RECEPTOR, AND CAR EXPRESSION
IN GUINEA PIG KNEE CARTILAGE
Spontaneous knee OA in male Hartley guinea pigs ap-
pears ﬁrst in the medial tibial plateau articular cartilage26e28.
The earliest changes in cartilage, including surface
lesions, typically are seen at 3e4 months of age, with
moderate OA developing by 6e12 months of age in the
medial tibial plateau cartilage26e28, ﬁndings that we
conﬁrmed here. In brief, we examined sections from 2-,
4- and 8-month-old Hartley guinea pig knee medial tibial
plateau articular cartilages. At 2 months of age, we
conﬁrmed that the medial tibial plateau articular cartilage
was grossly normal with a smooth surface (not shown),
and histologically, the same sites of cartilages of 2-month-
old animals also had a normal appearance, as assessed
by Safranin O staining (Fig. 1). By 4 months of age,
minor cartilage surface irregularity was conﬁrmed28 on
gross examination (not shown), and histologic changes
conﬁrming OA in the medial tibial plateau cartilage
included decreased Safranin O staining at the cartilage
surface, the development of vertical columns of chon-
drocytes (palisades), and moderately decreased cellularity
in the superﬁcial zone (Fig. 1). At 8 months of age, gross
surface erosions were detectable in medial tibial plateau
cartilage (not shown), and histologic changes included
marked decreases in both cellularity and Safranin O
staining in the superﬁcial zone, as well as palisading of
chondrocytes in the middle zone (Fig. 1). We did not
histologically examine the knee menisci in this study.
Immunohistochemistry for PTHrP, PTH/PTHrP receptor,
and CaR in serial sections from the same 2-, 4- and 8-
month-old guinea pig knees revealed that PTHrP expres-
sion was markedly up-regulated in the superﬁcial zone in
cartilages at 8 months of age, whereas CaR expression
was markedly up-regulated in the superﬁcial zone at 4
months of age, and the up-regulation of CaR expression
extended to the middle zone at 8 months of age (Fig. 1). In
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Tibiae from 2-, 4- and 8-month-old guinea pigs were dissected, decalciﬁed and embedded into parafﬁn, and medial tibial plateau central zone
articular cartilage sections (6 mm) were stained with hematoxylin/eosin (H & E) and Safranin O (left side panels) or analyzed by
immunohistochemistry for PTHrP, PTH/PTHrP receptor and CaR, as described in the Methods. Cartilages of 2-month-old animals had
a normal histologic appearance on H & E and Safranin O staining, but by 4 months of age, histologic changes conﬁrming OA in the medial
tibial plateau cartilage included decreased Safranin O staining at the cartilage surface, the development of vertical columns of chondrocytes
(palisades), and moderately decreased cellularity in the superﬁcial zone. At 8 months of age, histologic changes included a marked decrease
in both cellularity and Safranin O staining in the superﬁcial zone, as well as palisading of chondrocytes in the middle zone. The increased
PTHrP and CaR expression were detected as brown precipitates in the medial tibial plateau chondrocytes at 4 and/or 8 months of age, as
indicated (arrows). Negative controls (not shown) included omitting the primary antibody and, for PTHrP, preadsorbing the primary antibodies
with 100 molar excess of immunizing antigen. Positive controls for immunostaining (not shown) included sections from parafﬁn-embedded
human lung cancer-derived BEN cells and sections from parafﬁn-embedded osteogenic sarcoma-derived SaOS-2 cells. No signiﬁcant change
was observed for the PTH/PTHrP receptor immunostaining in the chondrocytes over the evolution of OA and the negative controls did not
demonstrate any speciﬁc staining in the chondrocytes (data not shown). The arrowheads in the immunohistochemistry panels indicate the
cartilage surface. Top left panel barZ 50 mm. Staining experiments were performed on guinea pig sections from at least three animals per
time point and staining was repeated at least once for each animal.contrast, PTH/PTHrP receptor expression in the superﬁcial
and middle zones did not appreciably change over the
same time period.
Next, we quantitatively analyzed PTHrP expression by
immunoassay in the tissue extracts of dissected medial
tibial plateau central zone hyaline cartilage and of meniscal
ﬁbrocartilage from the knees of 2-, 4- and 8-month-old
animals. Relative to normal samples at 2 months of age,
total PTHrP content was signiﬁcantly increased in whole
tissue extracts from the medial tibial plateau hyaline
cartilage at 4 months of age and 8 months of age (though
less abundant than at 4 months of age) (Fig. 2). Age-related
differences in PTHrP release in the conditioned media from
cultured chondrocytes isolated from guinea pig knee
articular hyaline cartilages were comparable to those seen
with the whole cartilage extracts (not shown). Meniscal
ﬁbrocartilage extracts also demonstrated a signiﬁcant in-
crease in PTHrP content, but this appeared only in samples
from 8-month-old animals (Fig. 2). Hence, chondrocyte
PTHrP expression changed as OA evolved over time in the
Hartley guinea pig knee.
FUNCTIONAL IMPLICATIONS OF CALCIUM-SENSING
IN CHONDROCYTIC CELLS
To better understand how calcium-sensing by chondro-
cytes might modulate OA, we initially studied ﬁrst passagenormal bovine articular chondrocytes and also employed
clonal, SV40 transformed chondrocytes from normal human
knee cartilage (CH-8 cells)29. Using RT-PCR, we observed
that the CH-8 cells (Fig. 3) and normal bovine knee
chondrocytes (not shown) expressed PTHrP, PTH/PTHrP
receptor, and CaR. Next, we incubated the chondrocytes in
medium containing subphysiologic, physiologic, and supra-
physiologic extracellular calcium concentrations (0.5, 1.8,
3.0 mM Ca2C, respectively). In parallel studies, we em-
ployed NPS R-467 (0e10 nM in medium containing 0.5 mM
Ca2C). NPS R-467 is a phenylalkylamine that acts as
a CaR agonist via allosterically modifying CaR function by
binding to CaR transmembrane domains and increasing
apparent afﬁnity of the CaR for Ca2C (Ref.33).
PTHrP secretion was increased at physiologic and
supraphysiologic extracellular Ca2C concentrations relative
to the subphysiologic concentration of 0.5 mM Ca2C in
bovine chondrocytes [Fig. 4(A)]. Furthermore, treatment
with the calcimimetic NPS R-467 directly stimulated PTHrP
secretion in bovine chondrocytes [Fig. 4(B)]. Speciﬁcally,
there was a w3-fold increase in PTHrP release at 1 nM
NPS R-467 and a w15-fold increase at 10 nM NPS R-467
compared to vehicle treated control. Because IL-1 was
previously established to stimulate PTHrP secretion by
human chondrocytes14, we next assessed for potential
effects of calcium-sensing on IL-1b-induced PTHrP secre-
tion in bovine chondrocytes. Treatment with IL-1 increased
399Osteoarthritis and Cartilage Vol. 13, No. 5the secretion of PTHrP by chondrocytes and this activity
was potentiated by increasing concentrations of extracellu-
lar Ca2C or of NPS R-467 [Fig. 4(AeB)].
Treatment with supraphysiologic extracellular calcium
concentration or with calcimimetic also inhibited TIMP-3
expression in bovine chondrocytes (Fig. 5). Speciﬁcally,
TIMP-3 expression was inhibited by w50% in medium
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Fig. 2. Changes in cartilage PTHrP content as OA evolves in the
Hartley guinea pig. Freshly dissected cartilage sections from 2-, 4-,
and 8-month-old Hartley guinea pigs were weighed and incubated
in situ for 48 h at 37(C in growth medium supplemented with 1%
serum, and PTHrP levels were measured in whole tissue extracts
by immunoassay, as described in the Methods. We sampled the
medial tibial plateau central zone of hyaline cartilage uncovered by
meniscus, as this zone develops the earliest OA lesions. We
concurrently sampled medial and lateral meniscal ﬁbrocartilage
from the same knees. The asterisks (*) indicate signiﬁcant
differences (P! 0.05) compared to the 2-month-old animals.
nZ 12 animals for each type of specimen at each age.
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Fig. 3. Chondrocytic CH-8 cells express PTH/PTHrP receptor
mRNA and CaR mRNA. RT-PCR for PTH/PTHrPR (parathyroid
hormone-related protein receptor), CaR and GAPDH was per-
formed on the Ch-8 cells (lane 2) as described in the Methods. The
PCR products generated from the cell lines using primers speciﬁc
for the PTHrP receptor, CaR and GAPDH were consistent with the
predicted product sizes, 615 bp, 461 bp and 206 bp, respectively.
A 100 bp DNA molecular weight ladder is shown on the left
(lane 1). Lane 3 had no PTH/PTHrPR or CaR primers added to the
PCR reaction.containing 3.0 mM Ca2C compared to medium containing
0.5 mM Ca2C, but was induced relative to vehicle control
alone by PTHrP treatment in cells in 3.0 mM Ca2C [Fig. 5(A,
B)]. Treatment of the cells with NPS R-467 dose-de-
pendently inhibited TIMP-3 expression under all conditions,
and was associated with failure of PTHrP to induce TIMP-3
[Fig. 5(C, D)]. For example, 10 nM NPS R-467 inhibited
TIMP-3 expression by O80% compared to vehicle treated
control cells [Fig. 5(C, D)].
To further understand the effects of calcium-sensing on
modulation of matrix catabolism, we concurrently assessed
MMP-13 and TIMP-3 expression. Because of limitations
related to cross-reactivity of available antibodies with
bovine MMP-13 (Foster, M, et al., unpublished observa-
tions), we carried out these studies in the human clonal
CH-8 chondrocytic cells (Fig. 6). We observed that
supraphysiologic extracellular Ca2C stimulated release of
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Fig. 4. PTHrP release in response to differing concentrations of
extracellular calcium or the CaR agonist (calcimimetic) NPS R-467
in cultured bovine articular chondrocytes. Aliquots of 3.0! 105 ﬁrst
passage normal bovine chondrocytes were cultured as described in
the Methods and treated as indicated with subphysiologic,
physiologic (1.8 mM), and supraphysiologic concentrations of
extracellular calcium or of the CaR agonist (calcimimetic) NPS R-
467 in 0.5 mM extracellular calcium. On the ﬁfth day of culture, the
conditioned media were collected and PTHrP 1-34 levels measured
by immunoassay. Data are pooled from of eight separate experi-
ments performed in duplicate. For panel A, asterisks (*) indicate
signiﬁcant differences (P! 0.05) in PTHrP release as compared to
no stimulation at individual calcium concentrations. There also was
a signiﬁcant difference (P! 0.05) in PTHrP release among control
groups at calcium concentrations other than physiologic (1.8 mM).
For panel B, asterisks (*) indicate signiﬁcant differences (P! 0.05)
in PTHrP release as compared to buffer alone with no NPS R-467.
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Fig. 5. TIMP-3 expression in response to differing concentrations of extracellular calcium and NPS R-467 in bovine chondrocytes. Aliquots of
3.0! 105 ﬁrst passage bovine chondrocytes were treated as described above and cell lysates collected on the ﬁfth day of culture were
analyzed by SDS-PAGE/Western blotting for TIMP-3 and alpha-tubulin and quantiﬁed by densitometry as described in the Methods. Results
are expressed as the integrated densitometric value (IDV) for the densitometric units of TIMP-3 normalized to alpha-tubulin. The asterisks (*)
indicate signiﬁcant differences (P! 0.05) for TIMP-3 relative to the control (physiologic calcium concentration (1.8 mM) open bar, panel B) or
vehicle only (no NPS R-467 added, open bar, panel D). Densitometry results shown are representative of ﬁve separate experiments and the
representative Western image for panel C was spliced together from the same gel.MMP-13 pro-enzyme, and the lower molecular weight form
of MMP-13 (activation band) also appeared in the condi-
tioned medium of cells treated with supraphysiologic
extracellular Ca2C [Fig. 6(A)]. The calcimimetic stimulated
release of MMP-13 pro-enzyme, but did not stimulate
formation of the MMP-13 activation band [Fig. 6(D)].
Supraphysiologic extracellular Ca2C inhibited TIMP-3 ex-
pression, but PTHrP demonstrated induction of TIMP-3 in
the presence of supraphysiologic extracellular Ca2C
[Fig. 6(A)]. Treatment with the calcimimetic suppressed
TIMP-3 expression under all conditions studied [Fig. 6(A, C,
D, F)]. Neither IL-1 nor PTHrP was able to induce MMP-13
at the subphysiologic extracellular Ca2C concentration of
0.5 mM, but either increasing extracellular Ca2C or adding
the calcimimetic allowed both IL-1 and PTHrP to induce
MMP-13 [Fig. 6(A, B, D, E)].
Discussion
In this study, we demonstrated marked up-regulation in
the expression of both the CaR and PTHrP in the course ofspontaneous knee OA in the Hartley guinea pig knee joint.
In the superﬁcial zone of the medial plateau of the Hartley
guinea pig knee, the site of the earliest OA lesions in this
model26, up-regulation of CaR expression preceded that of
PTHrP expression. In human cartilage with advanced OA,
PTHrP is up-regulated14. Here, we demonstrated PTHrP to
be sequentially up-regulated in the superﬁcial zone and
then the middle zone of the Hartley guinea pig knee medial
plateau cartilage. PTHrP is a critical regulator of growth
plate development3,6. Hence, PTHrP may be one of the
factors driving the chondrocyte proliferation (‘‘chondrocyte
cloning’’) known to develop in OA cartilage35, and up-
regulated PTHrP co-localized with proliferating chondro-
cytes in established, surgically induced OA in rabbit
knees15. PTHrP also might help ignite the endochondral
developmental cascade involved in osteophyte formation36.
But by promoting chondrocyte MMP-13 expression10, as
reinforced in this study, PTHrP also can contribute to
cartilage matrix degradation in OA37.
This study demonstrated CaR expression by ﬁrst
passage normal chondrocytes from bovine cartilage, as
well as chondrocytic human CH-8 cells, which permitted
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Fig. 6. MMP-13 and TIMP-3 expression in response to higher concentrations of calcium in CH-8 cells. Aliquots of 3.0! 105 CH-8 cells were
cultured as described in the Methods and on the ﬁfth day of culture, the conditioned media were collected for SDS-PAGE/Western blot
analyses of MMP-13 and cell lysates were collected for SDS-PAGE/Western blot analyses of TIMP-3 and alpha-tubulin (panels A and D). The
Western blots were quantiﬁed by densitometry and results are expressed as densitometric units of TIMP-3 normalized to alpha-tubulin, as
above, or non-normalized densitometric units of MMP-13 pro-enzyme and the MMP-13 activation band. For panels B and C, the asterisks (*)
indicate signiﬁcant differences (P! 0.05) in expression of pro-MMP-13 (panel B) or of the TIMP-3 band (panel C) as compared to control
(physiologic calcium (1.8 mM) open bar). For panels E and F, the asterisks (*) indicate signiﬁcant differences (P! 0.05) in expression of pro-
MMP-13 (panel E), and of TIMP-3 (panel F) as compared to the respective vehicle control (no NPS R-467 added, open bar). Densitometry
results shown are pooled from ﬁve separate experiments.investigation of functional aspects of calcium-sensing in
chondrocytic cells pertinent to pathogenesis of OA. A
noteworthy aspect of the experimental design was the
parallel study of altered extracellular calcium and of
the calcimimetic NPS R-467. We demonstrated that one
of the functions of calcium-sensing via the CaR inchondrocytes was to stimulate PTHrP expression. We also
observed that calcium-sensing via the CaR directly pro-
moted MMP-13 expression and suppressed expression of
the MMP and aggrecanase inhibitor TIMP-3. The signiﬁ-
cance of the observed suppressive effects of CaR-mediated
calcium-sensing on expression of TIMP-3 was underscored
402 D. W. Burton et al.: Calcium-sensing receptor in osteoarthritisby the lack of detectable TIMP-1 or TIMP-2 expression in the
cells cultured in this study (Foster, M, unpublished
observations). In the presence of supraphysiologic extra-
cellular calcium but not the calcimimetic, both MMP-13 pro-
enzyme and the MMP-13 activation band were induced.
These results suggested effects of extracellular calcium on
MMP-13 beyond cellular calcium-sensing, which may have
been exerted at the level of MMP-13 conformation and
MMP-13 susceptibility to post-translational modiﬁcations
including proteolysis38. Last, we observed that the CaR
calcimimetic potentiated the capacity of both PTHrP and IL-
1 to promote MMP-13 expression and suppress TIMP-3
expression. Interestingly, TIMP-3 expression was not sup-
pressed in response to PTHrP in bovine chondrocytes and
CH-8 cells cultured in supraphysiologic extracellular calci-
um, which was not the case in the cells treated with the
calcimimetic. We speculate that PTHrP effects on TIMP-3
expression might be subject to inﬂuence by cytosolic
calcium currents in addition to extracellular calcium-sensing.
Though the role of IL-1 in the induction of OA is not
entirely resolved, IL-1 appears to play a substantial role in
promoting cartilage matrix degradation in established
OA39,40. The induction of p44/42 mitogen-activated protein
kinase signaling and c-fos expression are among the
signals that transduce responses including expression of
certain MMPs in IL-1-treated chondrocytes41,42. In this
context, IL-1 signaling has previously been observed to
require calcium uptake to activate p44/42 signaling and
c-fos expression, and extracellular calcium depletion
decreases these particular responses42. Cellular uptake of
calcium, as opposed to membrane calcium-sensing, has
been reported to modulate the expression of certain
MMPs43,44. But it is noteworthy that one of the responses
mediated by calcium-sensing via the CaR is modulation of
cellular calcium uptake45. It also is conceivable that
extracellular calcium concentrations might rise in some
micro-environments within articular cartilage in which
calciﬁc crystalline deposits of hydroxyapatite and calcium
pyrophosphate dihydrate are formed or resorbed, and such
pathologic calciﬁcation is a common occurrence in de-
generative joint disease46.
The results of this study reinforce the importance of both
extracellular calcium concentration and CaR-mediated
calcium-sensing for maximal induction of MMP-13 expres-
sion by IL-1, and additionally by PTHrP. It will be of interest
to determine if CaR-mediated calcium-sensing modulates
protein kinase A pathway activation, which has previously
been observed to transduce the capacity of PTHrP 1-34 to
stimulate MMP-13 expression in chondrocytes47.
The primary agonist of the CaR is extracellular calcium,
and, conversely, the CaR acts as the principal cell sensor
for extracellular calcium19,20. However, the effective con-
centration to cause 50% of the mean maximum response
(EC50) for calcium to activate the CaR is typically supra-
physiologic (3e4 mM) in cells cultured from most types of
tissues19,20, In this regard, alternative, higher afﬁnity ligands
to calcium for the CaR also exist, including the polyamine
spermine, and the divalent cations Zn2C and Fe2C
(Refs.19,20). As such, there are open questions about the
breadth of potential housekeeping functions and degener-
ative joint disease-related functions of the CaR and the
range of CaR ligands involved, particularly given the
demonstration herein of up-regulated CaR expression in
spontaneous knee OA in the Hartley guinea pig.
The focused framework of the current study did not extend
to examination of chondrocyte calcium inﬂux dependent or
independent of the CaR, or to G protein-receptor-coupledsignal transduction potentially mediated by CaR17e20
within chondrocytic cells, and we did not evaluate
MMP-13, TIMP-3, or PTHrP transcriptional regulation. In
addition, we have not examined the effects of calcium-
sensing on MMP-13 post-translational processing or net
MMP-13 catalytic activity. This leaves open for future study
several compelling questions, given the observed concur-
rent effects on MMP-13 and TIMP-3 released by chondro-
cytic cells and the larger signiﬁcance of MMP-13 processing
and of TIMP-3 regulatory effects on MMP-13 activity48e51
and cartilage metabolism52. Nevertheless, this study has
provided novel ﬁndings of dysregulated CaR expression in
early guinea pig knee OA, of dysregulated PTHrP expres-
sion in the same setting, and of signiﬁcant effects of calcium-
sensing via the CaR on PTHrP expression and on the
regulation of MMP-13 and TIMP-3 expression. Our results
indicate the potential of dysregulated CaR in early OA to
contribute to the pathogenesis and progression of the
disease.
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